Desjardins Insurance is part of Desjardins Group, a leading cooperative financial group in Canada, offering a broad range of insurance solutions designed to protect individuals, families and businesses. With expertise spanning property and casualty, as well as life and health insurance, Desjardins Insurance combines financial strength, local presence and a people-first approach to help Canadians safeguard what matters most.

The Firehood is a network and movement dedicated to increasing the participation, leadership and prosperity of women in technology. Through community-building, events and strategic connections, The Firehood supports women founders and leaders as they scale high-growth companies and expand their impact across the innovation ecosystem.

Inovia is a venture capital firm that partners with founders to build impactful and enduring global companies. The team leverages an operator-led mindset to provide founders with multi-stage support, mentorship, and access to a worldwide network. Inovia manages over US$2.2B with operations in Montreal, Toronto, Calgary, Bay Area, and London.

McMaster University is one of Canada’s leading research-intensive institutions, recognized for advancing innovation across health, science and entrepreneurship. With a strong focus on translating research into real-world impact, McMaster supports the development of breakthrough ideas, startups and technologies.

MaRS Discovery District is Canada’s leading urban innovation hub, helping high-potential startups grow across sectors including health, fintech, cleantech and emerging technology. By connecting founders to capital, market intelligence and strategic networks, MaRS helps accelerate Canadian innovation at scale.

Manatt Health is a leading professional services practice working at the intersection of health care, policy, strategy and innovation. Combining legal, consulting and regulatory expertise, Manatt Health helps organizations navigate complex challenges and drive meaningful change across the evolving health care landscape

Osler, Hoskin & Harcourt LLP is a leading business law firm with offices across Canada and in New York, advising clients on domestic and cross-border legal matters. Known for its expertise, collaborative approach and strong support for growth-stage and established businesses, Osler works with leaders across a wide range of industries.

For over 25 years, Genesys Capital has been investing at the leading edge of medical innovation and have a proven track record of identifying emerging bioscience opportunities and transforming them into commercially successful companies.

DMZ Ventures is a corporate fund that invests in pre-seed and seed-stage startups with cheques from $50,000 to $250,000. We mainly invest in B2B SaaS and tech-driven companies, while remaining open to select opportunities that offer a strong strategic fit.

MaRS Investment Accelerator Fund is one of Canada’s most active early-stage investors, backing ambitious technology founders from first cheque through seed stage. With deep roots in Ontario’s innovation ecosystem, MaRS IAF combines capital, mentorship and strong networks to help build globally competitive companies.

Maple Bridge Ventures invests in early‑stage, immigrant‑led technology companies across AgriFoodTech, HealthTech, and Enterprise Solutions. The firm backs globally ambitious founders whose perspectives, resilience, and global experience drive meaningful economic impact in Canada’s innovation economy. Maple Bridge invests at the pre‑seed and seed stages, writing initial cheques of $250,000 to $1 million.

Graphite Ventures is a trusted seed-stage venture capital firm investing in B2B software and hardware companies across Canada. The firm partners with founders at the early commercialization stage, providing hands-on support to help build capital-efficient businesses while preserving long-term strategic and financing optionality. With more than a decade of investing experience, Graphite actively supports over 100 Canadian B2B companies as they progress from early product-market fit to repeatable sales and scalable growth. Through its $120M Fund IV, Graphite makes initial seed investments of $500K to $1.5M in strong founding teams demonstrating early market traction.

Whitecap has been investing in Canadian companies for over 30 years and focus on early-stage (Seed and Series A) investments in Software and Healthcare companies.

CCRM Enterprises Inc., CCRM’s for-profit venture investment arm, creates value for regenerative medicine-based technologies and cell and gene therapy companies by making early stage investments while leveraging CCRM’s sector expertise and specialized infrastructure.

Cross-Border Impact Ventures invests in transformative health technology companies working across women’s, children’s and adolescent health. The firm focuses on ventures with the potential to improve outcomes at scale across global markets, backing innovation that delivers both impact and commercial opportunity

A Global Early Stage Tech Venture Capital Fund Investing In The World's Largest Market Opportunities Solving The Biggest Challenges For Humanity

Forum Ventures® is the leading early-stage fund, accelerator and venture studio for B2B SaaS startups. Based in New York and Toronto, they’re on a mission to make the B2B SaaS journey easier, more accessible, and successful for early-stage founders. They invest in founders at the earliest stages and work with them to launch, build and scale their businesses. To date, they have made 500+ pre-seed and seed investments globally across industries like fintech, healthcare, applied AI, AI infrastructure, vertical AI, supply chain, and more.

REDDS Capital is a California-based venture capital firm investing globally in early-stage startups. The firm partners with ambitious founders building innovative companies across sectors, with a focus on identifying high-potential opportunities early and supporting long-term growth through strategic capital and global perspective.

Esplanade HealthTech Ventures is Canada’s leading digital healthcare venture capital firm, investing in the US, Canada, Europe and Israel. Esplanade focuses on early-stage and high-growth companies shaping the future of healthcare delivery and actively empowering them to scale and grow. Esplanade has a strong focus on investment in women's health, including several investments in the menopause and osteoporosis space.

Panache Ventures is a leading Canadian pre-seed and seed fund that backs visionary entrepreneurs building high-growth technology companies. Known for moving early and working closely with founders, Panache supports startups with hands-on experience, national reach and a strong founder-first approach.

Vistara Growth provides flexible growth debt and equity solutions to technology companies across North America. By offering tailored capital for expansion, acquisitions and other growth initiatives, Vistara helps scaling businesses accelerate on their own terms with less dilution.

Renew Venture Capital is a US-based ventrue capital firm that produces excess returns for investors and changes inefficient, ineffective, and exclusionary systems for better outcomes. They invest exclusively on merit and in outcomes.

Cross-Border Impact Ventures is an impact-focused venture firm investing in health technology companies serving women, children and adolescents. With a mission centered on backing transformative innovation, the firm supports businesses developing solutions for large global markets at the intersection of health and impact.

Amplitude Ventures is a capital catalyst for highly innovative companies at the point of value acceleration. They work with Canada's most promising healthcare companies that share their vision of bringing groundbreaking technologies to patients. Amplitude is focused on building world-class Canadian companies in precision medicine and next-generation medical devices. Since 2012, the Amplitude team has deployed a venture growth model used to build Canadian companies with world-class management teams and scale companies to breakout potential. This model has been used to create, build, and grow companies, resulting in over $1 billion in company value.